No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Subscribe to our Pearce IP Blogs and BioBlast® to receive our updates via email.
Global - Intellectual Property (2025)
Asia Pacific - Intellectual Property (2025, 2024)
Winner - Asia Pacific and Greater China Region Awards 2025 - DEI: Outstanding Firm (2025)
Market Leading Intellectual Property Firm (2025)
Market Leading Intellectual Property Firm (2024)
Market Leading Intellectual Property Firm (2023)
Tier 3 for IP Proscecution (2024)
Tier 3 for IP Proscecution (2023)
Silver - Litigation (Australia) (2025)
Silver - Prosecution (Australia) (2025)
Bronze - Prosecution (New Zealand) (2025)
Bronze - Litigation (Australia) (2023, 2022, 2021)
Bronze -- Prosecution (Australia) (2024, 2023, 2022, 2021)
Finalist – Women in Law Awards – Boutique Diversity Firm of the Year (2022)
Finalist – Intellectual Property Team of the Year (2022)
Winner – Intellectual Property Team of the Year (2021)
Patent Prosecution (2025, 2024, 2023, 2022)
Trade Mark - Patent & Trade Mark Attorney Firms (2025)
Patent Disputes (2025)
The Only Leading Female Owned Life Sciences focussed IP Firm (2023)
Pearce IP ranked firm (2021)
Silver - Litigation & Prosecution Australia (2025)
Bronze - Litigation & Prosecution New Zealand (2025)
Litigation & Prosecution Australia (2024)
Best Law Firm - Australia (2026)
Shortlisted – Australian Firm of the Year (2022)
Australasia – Healthcare & Life Sciences (Q2 2025, Q1 2025, Q2 2024, Q1 2024, Q4 2023, Q3 2023, Q2 2023, Q3 2022, Q2 2022, Q1 2021, Q4 2020)
Cross-border – Healthcare & Life Sciences (Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024, Q1 2024, Q4 2023, Q3 2023, Q2 2023, Q1 2023)
Europe – Healthcare & Life Sciences (Q2 2025, Q1 2025)
Top Specialist Firm (2025)
5-Star Employer of Choice (2025)
Top Boutique Firm (2024)
5-Star Intellectual Property Law Firm (2021)
Doyles Leading Intellectual Property (2021, 2020)
Doyles Recommended Intellectual Property (2021)
Finalist – Intellectual Property Partner of the Year (2025, 2024, 2022)
Winner – Intellectual Property Partner of the Year (2023)
Intellectual Property: Patents – Global (2025)
Intellectual Property: Patents – Asia Pacific (2025)
Life Sciences - Asia Pacific (2025)
Intellectual Property: Patents – Asia Pacific (2024)
Life Sciences – Asia Pacific (2024)
Recommended - Leading Contentious Intellectual Property Lawyer in NSW (2025)
Most Influential Lawyers – Changemaker (2024, 2023, 2022)
5-Star Intellectual Property Lawyer – General IP (2021)
WIPR Leader (2025, 2024, 2023, 2022)
WIPR Diversity Champion (2025, 2022)
Top 100 Influential Women in IP (2021)
WIPR Leaders – Patents & Trade Marks (2022, 2021, 2020)
Gold – Litigation (2025)
Gold – Prosecution (2025)
Silver – Litigation (2024, 2023, 2022, 2021)
Recommended for litigation (2020)
IP management consultancy (2025, 2024)
Legal (2025, 2024)
Pharmaceuticals/life sciences (2024)
Global Leader (2022, 2021, 2020)
World Leading IP Strategist (2022, 2021, 2020)
Patent Star (2025, 2024, 2023, 2022, 2021)
Practitioner of the Year Finalist (2023)
Silver - Prosecution & Strategy (Australia) (2025)
Winner – Patent Lawyer of the Year (2022)
Shortlisted – Life Sciences Lawyer of the Year (2022)
Winner – Client Choice Award for Life Sciences (2022)
Winner - Executive of the Year (2024)
Finalist - Executive of the Year (2024)
Winner – Partner of the Year (SME Law) (2021)
Australasia - Dispute Resolution (Q1 2025)
Australasia – Healthcare & Life Sciences (Q2 2024, Q1 2024 Q4 2023, Q3 2023, Q2 2023, Q3 2022, Q2 2022, Q1 2021, Q4 2020, Q3 2020)
Asia-Pacific – Healthcare & Life Sciences (Q1 2024, Q4 2023, Q3 2023)
US – Healthcare & Life Sciences (Q4 2023, Q3 2023, Q2 2023)
Cross-border – Healthcare & Life Sciences (Q3 2024, Q2 2024, Q1 2024, Q4 2023, Q3 2023, Q2 2023, Q1 2023, Q4 2022, Q3 2021)
Canada – Healthcare & Life Sciences (Q4 2023, Q2 2023)
Europe – Healthcare & Life Sciences (Q4 2023)
Intellectual Property: Patents - Global (2025)
Intellectual Property: Patents - Asia Pacific (2025)
Intellectual Property: Patents - Asia Pacific (2024)
Patents Star (2025, 2024, 2023)
Silver – Litigation (2025, 2024, 2023, 2022)
Silver – Transactions (2025, 2024)
Ranked as a market leading Intellectual Property (2023)
Bronze - Enforcement & Litigation (Australia) (2025)
Intellectual Property (2026, 2025, 2024, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016)
Life Sciences (2026)
Patent Lawyer of the Year (2021)
Intellectual Property - Asia Pacific (2025)
Intellectual Property - Asia Pacific (2024)
Notable Practitioner (2025, 2024)
Litigation (2025, 2024, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016)
Bronze - Enforcement & Litigation (New Zealand) (2025)
Recommended individual – Enforcement & Litigation (2024, 2023, 2022)
IP Expert (2022)
Intellectual Property & Litigation (2024, 2023, 2022, 2019)
Bronze - Prosecution and Strategy (New Zealand) (2025)
Silver - Prosecution (New Zealand) (2025)
Recommended - Prosecution (New Zealand) (2024)
WIPR Leader (2024)
Notable Practitioner (2025)
Biotechnology Law (2024, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016, 2015, 2014, 2013, 2012, 2011, 2010, 2009)
WIPR Leader (2024, 2023, 2022)
Patent Leader (2023, 2022, 2021)
Notable Practitioner (2025)
Patent Star (2024, 2023, 2022, 2021, 2020)
Silver ranking – Prosecution (2025, 2024, 2023)
Highly Recommended – Prosecution (2023, 2022)
WIPR Leader (2024)
Recommended Individual (2025)
Leading Next Generation Leaders (2025)
Rising Star in Intellectual Property (2024)
Rising Star in Intellectual Property (2023)
Rising Star in Intellectual Property (2022)
Rising Star in Intellectual Property (2021)
By 2027, be the premier life sciences IP practice in
Australia and New Zealand.